Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 552

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Significance of M2-Polarized Tumor-Associated Macrophage in Pancreatic Cancer

Kurahara, Hiroshi, Shinchi, Hiroyuki, Mataki, Yuko, Maemura, Kousei, Noma, Hidetoshi, Kubo, Fumitake, Sakoda, Masahiko, Ueno, Shinichi, Natsugoe, Shoji, Takao, Sonshin·2011·Journal of Surgical Research

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jss.2009.05.026

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 40

  1. Silverberg, 1998, Cancer statistics, CA Cancer J Clin, 38, 2
  2. Liotta, 2001, The microenvironment of the tumor-host interface, Nature, 411, 375, 10.1038/35077241 · DOI · Paper page
  3. Mantovani, 2008, Tumor immunity: Effector response to tumor and role of the microenvironment, Lancet, 371, 771, 10.1016/S0140-6736(08)60241-X · DOI · Paper page
  4. Lewis, 2006, Distinct role of macrophages in different tumor micoenvironments, Cancer Res, 66, 605, 10.1158/0008-5472.CAN-05-4005 · DOI · Paper page
  5. Sica, 2006, Tumor-associated macrophages are a distinct M2 polarized population promoting tumor progression: Potential targets of anti-cancer therapy, Euro J Cancer, 42, 717, 10.1016/j.ejca.2006.01.003 · DOI · Paper page
  6. Pollard, 2004, Tumor-educated macrophages promote tumor progression and metastasis, Nature Rev Cancer, 4, 71, 10.1038/nrc1256 · DOI · Paper page
  7. Schoppmann, 2002, Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis, Am J Pathol, 161, 947, 10.1016/S0002-9440(10)64255-1 · DOI · Paper page
  8. Tamagawa, 1997, Pancreatic lymph nodal and plexus micrometastases detected by enriched polymerase chain reaction and nonradioisotopic single-strand conformation polymorphism analysis: A new predictive factor for recurrent pancreatic carcinoma, Clin Cancer Res, 3, 2143
  9. Kayahara, 1999, Analysis of para-aortic lymph node involvement in pancreatic carcinoma, Cancer, 85, 583, 10.1002/(SICI)1097-0142(19990201)85:3<583::AID-CNCR8>3.0.CO;2-J · DOI
  10. Pedrazzoli, 1998, Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas, Ann Surg, 228, 508, 10.1097/00000658-199810000-00007 · DOI · Paper page
  11. Kurahara, 2007, Impact of lymph node micrometastasis in patients with pancreatic head cancer, World J Surg, 31, 483, 10.1007/s00268-006-0463-0 · DOI
  12. Hanahan, 2000, The hallmarks of cancer, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9 · DOI · Paper page
  13. Joukov, 1996, A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt-4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases, EMBO J, 15, 290, 10.1002/j.1460-2075.1996.tb00359.x · DOI · Paper page
  14. Orlandini, 1996, Identification of a c- fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family, Proc Natl Acad Sci USA, 93, 11675, 10.1073/pnas.93.21.11675 · DOI · Paper page
  15. Banerji, 1999, LYVE-1, new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan, J Cell Biol, 144, 789, 10.1083/jcb.144.4.789 · DOI · Paper page
  16. Kahn, 2002, Monoclonal antibody D2-40, a new markers of lymphatic endothelium, react with Kaposi's sarcoma and a subset of angiosarcomas, Modern Pathol, 15, 434, 10.1038/modpathol.3880543 · DOI · Paper page
  17. Jeltsch, 1997, Hyperplasia of lymphatic vessels in VEGF-C transgenic mice, Science, 276, 1423, 10.1126/science.276.5317.1423 · DOI · Paper page
  18. Skobe, 2001, Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis, Nat Med, 7, 192, 10.1038/84643 · DOI · Paper page
  19. Shabo, 2008, Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival, Int J Cancer, 123, 780, 10.1002/ijc.23527 · DOI · Paper page
  20. Lissbrant, 2000, Tumor associated macrophages in human prostate cancer: Relation to clinicopathological variables and survival, Int J Oncol, 17, 445
  21. Ohno, 2004, Correlation of histological localization of tumor-associated macrophages with clinicopathological features in endometrial cancer, Anticancer Res, 24, 3335
  22. Koide, 2004, Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus, Am J Gastorenterol, 99, 1667, 10.1111/j.1572-0241.2004.30733.x · DOI
  23. Hanada, 2000, Prognostic value of tumor-associated macrophage count in human bladder cancer, Int J Urol, 7, 263, 10.1046/j.1442-2042.2000.00190.x · DOI · Paper page
  24. Lee, 2008, Prognostic significance of macrophage infiltration in leiomyosarcomas, Clin Cancer Res, 14, 1423, 10.1158/1078-0432.CCR-07-1712 · DOI
  25. Ohno, 2003, The degree of macrophage infiltration into the cancer cell nest is a significant predictor of survival in gastric cancer patients, Anticancer Res, 23, 5015
  26. Forssell, 2007, High macrophage infiltration along the tumor front correlates with improved survival in colon cancer, Clin Cancer Res, 13, 1472, 10.1158/1078-0432.CCR-06-2073 · DOI · Paper page
  27. Schneider, 2006, Role of lymphangiogenesis and lymphangiogenic factors during pancreatic cancer progression and lymphatic spread, Int J Oncol, 28, 883
  28. Ochi, 2007, Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis, Pancreas, 34, 444, 10.1097/mpa.0b13e31803dd307 · DOI
  29. Marks, 1999, Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumors, Br J Cancer, 80, 569, 10.1038/sj.bjc.6690393 · DOI · Paper page
  30. Kahn, 2002, A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors, Lab Invest, 82, 1255, 10.1097/01.LAB.0000028824.03032.AB · DOI
  31. Fogt, 2004, Identification of lymphatic vessels in malignant, adenomatous and normal colonic mucosa using the novel immunostain D2-40, Oncol Rep, 11, 47
  32. Birner, 2001, Lymphatic microvessel density as a novel prognostic factor in early-stage invasive cervical cancer, Int J Cancer, 95, 29, 10.1002/1097-0215(20010120)95:1<29::AID-IJC1005>3.0.CO;2-W · DOI
  33. Beasley, 2002, Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer, Cancer Res, 62, 1315
  34. Farrow, 2004, Inflammatory mechanisms contributing to pancreatic cancer development, Ann Surg, 239, 763, 10.1097/01.sla.0000128681.76786.07 · DOI
  35. Condeelis, 2006, Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis, Cell, 124, 263, 10.1016/j.cell.2006.01.007 · DOI · Paper page
  36. Stacker, 2002, Lymphangiogenesis and cancer metastasis, Nat Rev Cancer, 2, 573, 10.1038/nrc863 · DOI · Paper page
  37. Padera, 2002, Lymphatic metastasis in the absence of functional intratumor lymphatics, Science, 296, 1883, 10.1126/science.1071420 · DOI · Paper page
  38. Leu, 2000, Absence of functional lymphatics within a murine sarcoma; a molecular and functional evaluation, Cancer Res, 60, 4324
  39. Thun, 2002, Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues, J Natl Cancer Inst, 94, 252, 10.1093/jnci/94.4.252 · DOI · Paper page
  40. Iwata, 2007, Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis, Cancer Res, 67, 10181, 10.1158/0008-5472.CAN-07-2366 · DOI

Cited by

Metadata

Authors
Kurahara, H., Shinchi, H., Mataki, Y., Maemura, K., Noma, H., Kubo, F., Sakoda, M., Ueno, S., Natsugoe, S., & Takao, S.
Venue
Journal of Surgical Research
Publisher
Elsevier BV
Published
2011-05
Volume
167
Issue
2
Pages
e211-e219
ISSN
0022-4804 (ISSN-L)
OpenAlex
W2066469619
Cited by
552
References
2
FWCI
7.13
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.